li wang
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
qiang wang
Houston Methodist Research Institute
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
sumei wang
Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
wenyu wang
Seoul National University
Seoul, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
zibing wang
Department of Immunotherapy, Henan Provincial Cancer Hospital
Zhengzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
sudha warrier
Manipal Institute of Regenerative Medicine
Bangalore, India
Review Editor
Cancer Molecular Targets and Therapeutics
mohammad waseem
University of Maryland Eastern Shore
Princess Anne, United States
Review Editor
Cancer Molecular Targets and Therapeutics
liang wei
Xuzhou Medical University
Xuzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
claudia wiese
Colorado State University
Fort Collins, United States
Review Editor
Cancer Molecular Targets and Therapeutics
john f woolley
University of Liverpool
Liverpool, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
chung-pu wu
Chang Gung University
Taoyuan, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
hailong wu
Shanghai University of Medicine and Health Sciences
Shanghai, China
Review Editor
Cancer Molecular Targets and Therapeutics
ling wu
Baylor College of Medicine
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
ning wu
Institute of Oceanology, Chinese Academy of Sciences (CAS)
Qingdao, China
Review Editor
Cancer Molecular Targets and Therapeutics
zhixian wu
900 Hospital of the Joint Logistics Team of the Chinese PLA
Fuzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
gang xiao
Zhejiang University
Hangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics